MIZUHO MEDY CO., LTD. is a Japan-based company principally engaged in-vitro diagnostic pharmaceuticals business. The Company mainly provides in-vitro diagnostic pharmaceuticals, including immune serum ...
3925.T Double Standard Inc.
Aug. 13 Medy-Tox Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI Jun. 17 Tranche Update on Medy-Tox Inc.'s Equity Buyback Plan announced on June 9, 2026. CI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results